The government-owned Garden Reach Shipbuilders & Engineers firm on Monday informed the bourses that it has entered into a contract with the Government of India, Ministry of Defence, for orders worth Rs. 6,311.32 crore.

Zydus Cadila and global Pharma major SIFI announced that they have tied-up to market innovative IOLs (Intraocular lenses) and surgical products developed in Italy and licensed in India by SIFI to treat ophthalmic disorders in the Indian market.

Max India is set to enter businesses with adjacencies to current group businesses of life insurance, real estate, senior care and hospitality. The company is in the midst of selling 51 per cent stake in Health Insurance JV Max Bupa, to a leading private equity firm True North which is expected to be completed in the next six months.

Cipla with its subsidiary, Cipla USA has received approval for ANDA for Ambrisentan Tablets from the US drug regulator. The shares of the company were trading in red in the morning session.

Leading private banker Yes Bank's shares tumbled on Tuesday as the bank posted a loss of Rs. 1,507 crore for the March quarter. In the early morning session on Tuesday, the stock was down by more than 25 per cent at Rs. 177.90 per share.

Glenmark announced the launch of its patent-protected and globally-researched sodium glucose co-transporter-2 (SGLT2) inhibitor Remogliflozin etabonate in India. The drug is indicated in the treatment of type-2 diabetes mellitus in adults.

Overall volumes in futures & options currently stand at 1.10 crore contracts with a turnover of Rs. 7,32,837.82 crore.

Overall volumes in futures & options currently stand at 1.10 crore contracts with a turnover of Rs. 7,32,837.82 crore.

The previous week’s high of 11,797 is likely to act as a resistance level and a sustainable move above this level could set the stage for reclaiming the all-time high level of 11,856. On the downside, immediate support is seen around the level of 11,655, which is also the 20-day moving average. Stocks in news: JK Paper, Greaves Cotton, Sudarshan Chemical Industries, Sun Pharma, Dr Lal Pathlabs, Shankara Building Products, NBCC.

The Indian markets will resume trading after a long weekend and it will again go into another holiday on Wednesday this week. Hence, we might not see much action in the markets as traders might be reluctant to take any significant positions. However, we cannot rule out stock-specific action as over 40 companies are lined up to announce their earnings today. Looking at the early action among Asian peers and the SGX Nifty, the Nifty may open the day flat at 11,847 levels. Traders will also keep eye on India’s infrastructure output for the month of March which is due later in the day.